Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract

Abstract

The combination of gemcitabine plus carboplatin achieves a similar result to doublets using cisplatin. It has an acceptable toxicity profile and enables patients with impaired renal function and/or poor performance status and elderly patients to be treated.